Janney Montgomery Scott LLC Regeneron Pharmaceuticals, Inc. Transaction History

Janney Montgomery Scott LLC

  • $32.8 Billion
  • Q2 2024

A detailed history of Janney Montgomery Scott LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 20,009 shares of REGN stock, worth $22.9 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
20,009
Previous 26,907 25.64%
Holding current value
$22.9 Million
Previous $25.9 Million 18.8%
% of portfolio
0.06%
Previous 0.08%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024
SELL
$883.2 - $1071.19 $6.09 Million - $7.39 Million
-6,898 Reduced 25.64%
20,009 $21 Million
Q1 2024

May 01, 2024
BUY
$902.69 - $993.35 $2.34 Million - $2.58 Million
2,593 Added 10.66%
26,907 $25.9 Million
Q4 2023

Feb 07, 2024
BUY
$775.18 - $881.7 $5.03 Million - $5.72 Million
6,485 Added 36.37%
24,314 $21.4 Million
Q3 2023

Nov 08, 2023
BUY
$692.45 - $844.37 $842,019 - $1.03 Million
1,216 Added 7.32%
17,829 $14.7 Million
Q2 2023

Jul 26, 2023
BUY
$700.03 - $830.35 $800,834 - $949,920
1,144 Added 7.4%
16,613 $11.9 Million
Q1 2023

Apr 28, 2023
BUY
$680.49 - $826.97 $6.92 Million - $8.4 Million
10,163 Added 191.54%
15,469 $12.7 Million
Q4 2022

Feb 01, 2023
BUY
$705.89 - $766.39 $916,951 - $995,540
1,299 Added 32.42%
5,306 $3.83 Million
Q3 2022

Oct 25, 2022
SELL
$573.97 - $724.32 $1.19 Million - $1.5 Million
-2,072 Reduced 34.08%
4,007 $2.76 Million
Q2 2022

Aug 03, 2022
SELL
$548.35 - $738.84 $8.62 Million - $11.6 Million
-15,723 Reduced 72.12%
6,079 $3.61 Million
Q1 2022

May 04, 2022
SELL
$595.12 - $698.43 $1.29 Million - $1.51 Million
-2,165 Reduced 9.03%
21,802 $15.2 Million
Q4 2021

Jan 27, 2022
SELL
$543.48 - $670.97 $1.5 Million - $1.86 Million
-2,766 Reduced 10.35%
23,967 $15.1 Million
Q3 2021

Oct 29, 2021
BUY
$574.03 - $680.96 $466,686 - $553,620
813 Added 3.14%
26,733 $16.2 Million
Q2 2021

Jul 26, 2021
BUY
$472.8 - $558.54 $802,341 - $947,842
1,697 Added 7.01%
25,920 $14.5 Million
Q1 2021

Apr 27, 2021
BUY
$446.73 - $548.2 $6.12 Million - $7.51 Million
13,693 Added 130.04%
24,223 $11.5 Million
Q4 2020

Jan 25, 2021
SELL
$478.3 - $607.98 $931,250 - $1.18 Million
-1,947 Reduced 15.6%
10,530 $5.09 Million
Q3 2020

Nov 06, 2020
BUY
$544.75 - $658.21 $1.37 Million - $1.66 Million
2,521 Added 25.32%
12,477 $6.98 Million
Q2 2020

Jul 23, 2020
BUY
$493.32 - $643.92 $842,097 - $1.1 Million
1,707 Added 20.69%
9,956 $6.21 Million
Q1 2020

Apr 30, 2020
BUY
$336.18 - $494.43 $453,170 - $666,491
1,348 Added 19.53%
8,249 $4.03 Million
Q4 2019

Jan 21, 2020
BUY
$274.13 - $376.51 $1.09 Million - $1.5 Million
3,988 Added 136.9%
6,901 $2.59 Million
Q3 2019

Oct 29, 2019
SELL
$273.46 - $318.39 $1.47 Million - $1.71 Million
-5,363 Reduced 64.8%
2,913 $808,000
Q2 2019

Jul 29, 2019
SELL
$299.6 - $414.82 $208,222 - $288,299
-695 Reduced 7.75%
8,276 $2.59 Million
Q1 2019

Apr 30, 2019
BUY
$372.08 - $439.57 $1.47 Million - $1.74 Million
3,949 Added 78.63%
8,971 $3.68 Million
Q4 2018

Feb 01, 2019
SELL
$335.82 - $403.04 $199,477 - $239,405
-594 Reduced 10.58%
5,022 $1.88 Million
Q3 2018

Nov 05, 2018
BUY
$351.14 - $408.51 $377,475 - $439,148
1,075 Added 23.67%
5,616 $2.27 Million
Q2 2018

Jul 24, 2018
BUY
$284.6 - $344.99 $95,625 - $115,916
336 Added 7.99%
4,541 $1.57 Million
Q1 2018

Apr 19, 2018
SELL
$315.82 - $393.78 $171,174 - $213,428
-542 Reduced 11.42%
4,205 $1.45 Million
Q4 2017

Feb 14, 2018
BUY
$358.63 - $469.95 $11,476 - $15,038
32 Added 0.68%
4,747 $1.79 Million
Q3 2017

Nov 15, 2017
BUY
$431.38 - $504.0 $2.03 Million - $2.38 Million
4,715
4,715 $2.11 Million

Others Institutions Holding REGN

# of Institutions
1,461
Shares Held
84.5M
Call Options Held
907K
Put Options Held
1.3M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $123B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email